Century Therapeutics, Inc. Segments Disclosure
Note 19 – Segment Reporting
Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (“CODM”) in making decisions on how to allocate resources and assess performance. The Company views its operations and manages the business as one operating segment. The Company’s CODM is its Chief Executive Officer. The CODM uses research and development expenses, general and administrative expenses, and net loss as measures of profit or loss to assess performance and allocate resources, all of which are presented on the face of the financial statements. The CODM also uses a further breakdown of research and development expenses to assess performance and allocate resources as presented below:
Year Ended | Year Ended | |||||
December 31, 2024 | December 31, 2023 | |||||
Collaboration revenue | $ | 6,589 | $ | 2,235 | ||
Less cost and expense: | ||||||
Research and development | ||||||
Personnel and related costs |
| $ | 42,398 |
| $ | 41,826 |
Facility and other allocated costs |
| 22,485 |
| 24,411 | ||
Research and laboratory |
| 30,655 |
| 23,816 | ||
Other research and development |
| 11,706 |
| 2,657 | ||
General and administrative | 33,155 | 34,706 | ||||
Other segment (income)/expense | (7,244) | 11,492 | ||||
Net loss | $ | (126,566) | $ | (136,673) | ||
Other segment (income)/expense includes in-process research and development, impairment of long-lived assets, impairment of goodwill, interest expense, interest income, other income (expense), and provision for income taxes.
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.